FINWIRES · TerminalLIVE
FINWIRES

Civmec Posts Higher Revenue, EBITDA in March Quarter; Shares Up 6%

By

Civmec (ASX:CVL) posted revenue of A$244.2 million and earnings before interest, taxes, depreciation, and amortization (EBITDA) of AU$27.8 million during the quarter ended March 31, according to a Friday filing with the Australian bourse.

The company reported revenue of AU$158.5 million and EBITDA of AU$19.2 million in the same time last year, an earlier filing showed.

Net profit for the quarter was AU$13.5 million, the filing said.

Net profit during the previous corresponding period was AU$8 million.

Civmec shares rose 6% in morning trade on Friday.

Related Articles

Asia

Alibaba Health Seeks 10 Billion Yuan Share Premium Cut to Support Dividends; Shares Fall 7%

Alibaba Health Information Technology (HKG:0241) proposed a 10 billion yuan reduction in its share premium account to facilitate dividend distributions, according to a Thursday Hong Kong bourse filing.Shares of the digital health service provider fell 7% in late morning trade on Friday.The company said the proposed reduction would transfer the amount from its share premium account to contributed surplus, enabling payment of a final dividend and a special dividend for the year ended March 31.Alibaba Health proposed a final dividend of 0.0595 yuan per share and a special dividend of 0.1352 yuan per share.The company said the proposal was necessary because it had insufficient contributed surplus available for distribution.Alibaba Health's share premium account stood at about 51.7 billion yuan as of March 31, the filing showed.

$HKG:0241
Asia

Prestige Biologics Secures KRW2.4 Billion Contract Manufacturing Agreement for APIs

Prestige Biologics (KOSDAQ:334970) secured a contract manufacturing agreement for active pharmaceutical ingredients (APIs) following a technology transfer from an undisclosed client, according to a Friday filing with the Korea Exchange.The deal, valued at 2.40 billion won, is valid till March 31, 2027.Shares of Prestige Biologics fell nearly 2% in recent trade.

$KOSDAQ:334970
Asia

Thai Beverage's Attributable Profit Up 9% in Fiscal Q2

Thai Beverage's (SGX:Y92) attributable profit to owners rose 9% during the fiscal second quarter ended March 31 to 7.37 billion baht from 6.74 billion baht a year earlier, according to a Thursday filing with the Singapore Exchange.Shares of the beverage producer were up over 1% in Friday trading.Earnings per share came in at 0.29 baht compared with 0.27 baht in the year-ago period.Revenue from sale of goods inched up 1% year over year to 86.5 billion baht from 85.4 billion baht.The board approved an interim dividend of 0.15 baht per share for the period, unchanged from a year earlier. The dividend will be paid on June 12.

$SGX:Y92